EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation

Mona Daghaighei iD, Samaneh Dodge iD, Soheil Bolandi iD, Boutros Youssef iD, Niket Attarde iD, Moein Maddahi iD, Maryam Mostofi iD, Reza Morovatshoar iD, Mehrnaz Mostafavi iD, Dejbakht Majid iD, Mohammadamin Joulani iD, Pegah Tamimi iD und 4 weitere

Journal of Immunology Research · 2025

DOI: 10.1155/jimr/8890939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Mona Daghaighei und 15 weiteren Autor:innen. Beteiligte Einrichtung: Islamic Azad University of Tehran, Medical Branch, Tehran, Iran. Hauptthemen laut MEDLINE: Melanoma, Interleukin-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Melanoma is a complex malignancy where the interplay between immune cells, cytokines, and the tumor microenvironment (TME) significantly influences disease progression and patient outcomes. This review explores the involvement of the interleukin‐2 (IL‐2) cytokine family in both the development and therapeutic approaches for melanoma.

Methods

A narrative literature review was conducted, synthesizing findings from studies on immune cell behavior, cytokine functions, and their implications in melanoma and other cancers. This narrative review emphasizes the roles of immune cells and cytokines in both promoting and inhibiting tumor growth.

Results

Neutrophils, influenced by tumor‐derived cytokines, can adopt phenotypes that either inhibit or promote tumor growth. B cells in the TME often correlate with better survival, although their regulatory forms can suppress immune responses. Tissue‐resident memory T cells (TRM cells) are crucial for antitumor immunity, particularly in response to immune checkpoint inhibitors (ICIs). Dendritic cells (DCs) are vital for antigen presentation, yet their function can be compromised in melanoma. Macrophages frequently support tumor growth through immunosuppressive actions. The IL‐2 cytokine family, including IL‐2, IL‐4, IL‐7, IL‐9, IL‐15, and IL‐21, plays diverse roles in immune regulation. These cytokines are involved in T‐cell proliferation, B‐cell differentiation, and modulation of other immune responses, influencing both tumor progression and the effectiveness of immunotherapies.

Conclusions

Immune cells and cytokines are pivotal in the pathogenesis, progression, and immunotherapy of melanoma. Understanding their complex roles offers insights into potential therapeutic strategies, highlighting the importance of targeted immunotherapies in treating melanoma and possibly other cancers. Additional studies are required to clarify the precise mechanisms and interactions occurring within the TME to enhance treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaInterleukin-2HumansTumor MicroenvironmentAnimalsImmunotherapyImmunomodulationDendritic Cells

Stichwörter der Autor:innen

cytokinesimmunotherapyinterleukininterleukin-2 familymelanoma

Substanzen

Interleukin-2

Autor:innen und Institutionen

  • Islamic Azad University of Tehran, Medical Branch, Tehran, Iran.
  • School of Pharmacy, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Cardiovascular Diseases, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.
  • Department of Medicine, Dr D Y Patil Medical College, Navi Mumbai, India.
  • Department of Medicine, Yeditepe University of Medical Sciences, Istanbul, Türkiye.

ORCID-Profile: Mona Daghaighei, Samaneh Dodge, Soheil Bolandi, Boutros Youssef, Niket Attarde, Moein Maddahi, Maryam Mostofi, Reza Morovatshoar, Mehrnaz Mostafavi, Dejbakht Majid, Mohammadamin Joulani, Pegah Tamimi, Malihe Sharafi, Qumars Behfar, Yasaman Ghodsi Boushehri, Alireza Azani

Zitieren

APA

Daghaighei, M., Dodge, S., Bolandi, S., Youssef, B., Attarde, N., Maddahi, M., Mostofi, M., Morovatshoar, R., Mostafavi, M., Majid, D., Joulani, M., Tamimi, P., Sharafi, M., Behfar, Q., Boushehri, Y. G., & Azani, A. (2025). The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation. Journal of Immunology Research. https://doi.org/10.1155/jimr/8890939

Vancouver

Daghaighei M, Dodge S, Bolandi S, Youssef B, Attarde N, Maddahi M, et al. The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation. Journal of Immunology Research. 2025. doi:10.1155/jimr/8890939

BibTeX
@article{Daghaighei2025,
  author = {Daghaighei, Mona and Dodge, Samaneh and Bolandi, Soheil and Youssef, Boutros and Attarde, Niket and Maddahi, Moein and Mostofi, Maryam and Morovatshoar, Reza and Mostafavi, Mehrnaz and Majid, Dejbakht and Joulani, Mohammadamin and Tamimi, Pegah and Sharafi, Malihe and Behfar, Qumars and Boushehri, Yasaman Ghodsi and Azani, Alireza},
  title = {The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation},
  journal = {Journal of Immunology Research},
  year = {2025},
  doi = {10.1155/jimr/8890939}
}
Kostenlos starten →